Vaporesección/ vapoenucleación de próstata con láser thulium frente a prostatectomía abierta en próstatas de alto volumen

Vista sencilla de ítem
dc.contributor.advisorSalazar Rey, Milton
dc.contributor.advisorCamacho López, Paul Anthony
dc.contributor.apolounabCamacho López, Paul Anthony [paul-anthony-camacho-lópez]
dc.contributor.authorSandoval Ojeda, Juan Manuel
dc.contributor.cvlacSalazar Rey, Milton [0001489804]spa
dc.contributor.cvlacCamacho López, Paul Anthony [0000323578]spa
dc.contributor.googlescholarCamacho López, Paul Anthony [u8d7_QAAAAJ]spa
dc.contributor.linkedinCamacho López, Paul Anthony [paulcamachomdepi]
dc.contributor.orcidSalazar Rey, Milton [0000-0002-1316-4149]spa
dc.contributor.orcidCamacho López, Paul Anthony [0000-0002-6233-9582]spa
dc.contributor.researchgateSalazar Rey, Milton [Milton-Salazar-Rey-31568627]spa
dc.contributor.researchgateCamacho López, Paul Anthony [Paul_Camacho_Lopez]spa
dc.contributor.scopusCamacho López, Paul Anthony [16047325700]spa
dc.coverage.campusUNAB Campus Bucaramangaspa
dc.coverage.spatialFloridablanca (Santander, Colombia)spa
dc.coverage.temporal2017-2020spa
dc.date.accessioned2022-07-11T18:26:54Z
dc.date.available2022-07-11T18:26:54Z
dc.date.issued2022-06-14
dc.degree.nameEspecialista en Urologíaspa
dc.description.abstractLa hiperplasia prostática benigna (HPB) es un diagnóstico histológico de proliferación de músculo liso y células epiteliales en la zona transicional. Tiene una prevalencia del 50% en hombres de 50 años y hasta 80% a los 80 años. La principal manifestación clínica son los síntomas del tracto urinario inferior (SUOB), alcanzando una prevalencia de 45.2%. La resección transuretral de próstata (RTUP) se consideró el Gold estándar en próstatas de bajo volumen (< 80 cc) y para próstatas de alto volumen (> de 80 cc) fue la prostatectomía abierta (PA), con altas tasas de efectividad y un margen aceptable de seguridad. En la actualidad, existen alternativas endoscópicas con tecnología Láser (Holmium, Green laser, Thulium). En la población colombiana, no se cuenta con datos de efectividad de una técnica frente a otra en pacientes en próstatas de alto volumen. El objetivo del estudio es analizar la efectividad, costos y desenlaces de los pacientes sometidos a procedimientos endoscópicos Laser vs abierto.spa
dc.description.abstractenglishBenign prostatic hyperplasia (BPH) is a histological diagnosis of smooth muscle and epithelial cell proliferation in the transitional zone. It has a prevalence of 50% in men aged 50 years and up to 80% at the age of 80 years. The main clinical manifestation is lower urinary tract symptoms (LUTS), reaching a prevalence of 45.2%. Transurethral resection of the prostate (TURP) was considered the Gold standard in low-volume prostates (< 80 cc) and for high-volume prostates (> 80 cc) it was open prostatectomy (OP), with high effectiveness rates and an acceptable margin of safety. Currently, there are endoscopic alternatives with laser technology (Holmium, Green laser, Thulium). In the Colombian population, there is no data on the effectiveness of one technique versus another in patients with high volume prostates. The objective of the study is to analyze the effectiveness, costs and outcomes of patients submitted to endoscopic Laser vs. open procedures.spa
dc.description.degreelevelEspecializaciónspa
dc.description.learningmodalityModalidad Presencialspa
dc.description.tableofcontentsLISTA DE TABLAS 6 LISTA DE FIGURAS 7 LISTA DE ANEXOS 8 GLOSARIO 9 RESUMEN 10 INTRODUCCIÓN 14 1. DESCRIPCIÓN DEL PROYECTO 15 1.1 Planteamiento del problema y justificación 15 1.2 Pregunta de investigación 16 2.1. Marco Teórico 17 2.2. Estado del Arte 22 2.3. Objetivos 25 2.4.1. Objetivo general 25 2.4.2. Objetivos específicos 25 2.5. Metodología 26 2.5.1. Diseño 26 2.5.2. Universo 26 2.5.3. Población Objeto 26 2.5.4. Criterios de elegibilidad 26 2.5.4.1. Criterios de Inclusión 26 2.5.4.2. Criterios de Exclusión 26 2.5.5. Descripción del procedimiento 27 5 2.5.6. plan de análisis de datos 27 3. CONSIDERACIONES ÉTICAS 29 4. RESULTADOS 31 5. DISCUSIÓN 39 6. CONCLUSIONES 42 7. REFERENCIAS BIBLIOGRÁFICAS 43spa
dc.format.mimetypeapplication/pdfspa
dc.identifier.instnameinstname:Universidad Autónoma de Bucaramanga - UNABspa
dc.identifier.reponamereponame:Repositorio Institucional UNABspa
dc.identifier.repourlrepourl:https://repository.unab.edu.cospa
dc.identifier.urihttp://hdl.handle.net/20.500.12749/16888
dc.language.isospaspa
dc.publisher.facultyFacultad Ciencias de la Saludspa
dc.publisher.grantorUniversidad Autónoma de Bucaramanga UNABspa
dc.publisher.programEspecialización en Urologíaspa
dc.relation.references1. Bartsch, G., Müller, H. R., Oberholzer, M., & Rohr, H. P. (1979). Light microscopic stereological analysis of the normal human prostate and of benign prostatic hyperplasia. The Journal of Urology, 122(4), 487–491. https://doi.org/10.1016/s0022-5347(17)56476-spa
dc.relation.references2. Vuichoud, C., & Loughlin, K. R. (2015). Benign prostatic hyperplasia: epidemiology, economics and evaluation. The Canadian journal of urology, 22 Suppl 1, 1–6.spa
dc.relation.references3. Bartsch, G., Müller, H. R., Oberholzer, M., & Rohr, H. P. (1979). Light microscopic stereological analysis of the normal human prostate and of benign prostatic hyperplasia. The Journal of Urology, 122(4), 487– 491. https://doi.org/10.1016/s0022-5347(17)56476-9spa
dc.relation.references4. Irwin, D. E., Kopp, Z. S., Agatep, B., Milsom, I., & Abrams, P. (2011). Worldwide prevalence estimates of lower urinary tract symptoms, overactive bladder, urinary incontinence and bladder outlet obstruction. BJU international, 108(7), 1132–1138. https://doi.org/10.1111/j.1464410X.2010.09993.xspa
dc.relation.references5. McConnell, J. D., Roehrborn, C. G., Bautista, O. M., Andriole, G. L., Jr, Dixon, C. M., Kusek, J. W., Lepor, H., McVary, K. T., Nyberg, L. M., Jr, Clarke, H. S., Crawford, E. D., Diokno, A., Foley, J. P., Foster, H. E., Jacobs, S. C., Kaplan, S. A., Kreder, K. J., Lieber, M. M., Lucia, M. S., … Medical Therapy of Prostatic Symptoms (MTOPS) Research Group. (2003). The long-term effect of doxazosin, finasteride, and combination therapy on the clinical progression of benign prostatic hyperplasia. The New England Journal of Medicine, 349(25), 2387– 2398. https://doi.org/10.1056/NEJMoa030656spa
dc.relation.references6. Lourenco, T., Pickard, R., Vale, L., Grant, A., Fraser, C., MacLennan, G., N’Dow, J., & Benign Prostatic Enlargement team. (2008). Alternative approaches to endoscopic ablation for benign enlargement of the prostate: systematic review of randomised controlled trials. BMJ (Clinical Research Ed.), 337(jun30 1), a449. https://doi.org/10.1136/bmj.39575.517674.BEspa
dc.relation.references7. Deliveliotis, C., Liakouras, C., Delis, A., Skolarikos, A., Varkarakis, J., & Protogerou, V. (2004). Prostate operations: long-term effects on sexual and urinary function and quality of life. Comparison with an age-matched control population. Urological Research, 32(4), 283– 289. https://doi.org/10.1007/s00240-004-0411-0spa
dc.relation.references8. Xia S.-J., Zhang Y.-N., Lu J., Sun X.-W., Zhang J., Zhu Y.-Y., & Li W.-G. (2005). Thulium laser resection of prostate-tangerine technique in treatment of benign prostate hyperplasia. Zhonghua yi xue za zhi, 85(45), 3225–3228. https://pubmed.ncbi.nlm.nih.gov/16405847/spa
dc.relation.references9. Bach, T., Xia, S. J., Yang, Y., Mattioli, S., Watson, G. M., Gross, A. J., & Herrmann, T. R. W. (2010). Thulium: YAG 2 mum cw laser prostatectomy: where do we stand? World Journal of Urology, 28(2), 163–168. https://doi.org/10.1007/s00345-010-0522-xspa
dc.relation.references10. Lee, C., Kozlowski, J. M., & Grayhack, J. T. (1995). Etiology of benign prostatic hyperplasia. The Urologic Clinics of North America, 22(2), 237–246. https://pubmed.ncbi.nlm.nih.gov/7539172/spa
dc.relation.references11. Isaacs, J. T., & Coffey, D. S. (1989). Etiology and disease process of benign prostatic hyperplasia. The Prostate. Supplement, 2, 33–50. https://doi.org/10.1002/pros.2990150506spa
dc.relation.references12. Tanagho, E. A., & McAninch, J. W. (2008). Smith’s General Urology (17a ed.). McGraw-Hill Medicalspa
dc.relation.references13. McVary, K. T. (2006). BPH: epidemiology and comorbidities. The American Journal of Managed Care, 12(5 Suppl), S122-8. https://pubmed.ncbi.nlm.nih.gov/16613526/spa
dc.relation.references14. Castro Muñoz, Juan Carlos, & Gonzáles Encinales, César, & Rozo Maragua, Luis Ernesto, & Reyes Calderón, Jesús Antonio (2007). Estudio de Fármacovigilancia en pacientes con Hiperplasia Prostática Benigna (HPB) sintomática tratados con Tamsulosina 0.4 mg en 8 ciudades de Colombia. Revista Urología Colombiana, XVI(1),107117.[fecha de Consulta 8 de Junio de 2022]. ISSN: 0120-789X. Disponible en: https://www.redalyc.org/articulo.oa?id=149120468014spa
dc.relation.references15. Lerner, L. B., McVary, K. T., Barry, M. J., Bixler, B. R., Dahm, P., Das, A. K., Gandhi, M. C., Kaplan, S. A., Kohler, T. S., Martin, L., Parsons, J. K., Roehrborn, C. G., Stoffel, J. T., Welliver, C., & Wilt, T. J. (2021). Management of Lower Urinary Tract Symptoms Attributed to Benign Prostatic Hyperplasia: AUA GUIDELINE PART I-Initial Work-up and Medical Management. The Journal of urology, 206(4), 806–817. https://doi.org/10.1097/JU.0000000000002183spa
dc.relation.references16. Irwin, D. E., Milsom, I., Hunskaar, S., Reilly, K., Kopp, Z., Herschorn, S., Coyne, K., Kelleher, C., Hampel, C., Artibani, W., & Abrams, P. (2006). Population-based survey of urinary incontinence, overactive bladder, and other lower urinary tract symptoms in five countries: results of the EPIC study. European urology, 50(6), 1306– 1315. https://doi.org/10.1016/j.eururo.2006.09.019spa
dc.relation.references17. D'Silva, K. A., Dahm, P., & Wong, C. L. (2014). Does this man with lower urinary tract symptoms have bladder outlet obstruction?: The Rational Clinical Examination: a systematic review. JAMA, 312(5), 535– 542. https://doi.org/10.1001/jama.2014.5555spa
dc.relation.references18. Barry, M. J., Fowler, F. J., Jr, O'Leary, M. P., Bruskewitz, R. C., Holtgrewe, H. L., Mebust, W. K., & Cockett, A. T. (1992). The American Urological Association symptom index for benign prostatic hyperplasia. The Measurement Committee of the American Urological Association. The Journal of urology, 148(5), 1549–1564. https://doi.org/10.1016/s0022-5347(17)36966-5spa
dc.relation.references19. Sirls, L. T., Kirkemo, A. K., & Jay, J. (1996). Lack of correlation of the American Urological Association Symptom 7 Index with urodynamic bladder outlet obstruction. Neurourology and urodynamics, 15(5), 447– 457. https://doi.org/10.1002/(SICI)1520-6777(1996)15:5spa
dc.relation.references20. Donovan, J. L., Peters, T. J., Abrams, P., Brookes, S. T., de aa Rosette, J. J., & Schäfer, W. (2000). Scoring the short form ICSmaleSF questionnaire. International Continence Society. The Journal of Urology, 164(6), 1948–1955. https://pubmed.ncbi.nlm.nih.gov/11061889/spa
dc.relation.references21. Rassweiler, J., Teber, D., Kuntz, R., & Hofmann, R. (2006). Complications of transurethral resection of the prostate (TURP)-incidence, management, and prevention. European urology, 50(5), 969– 980. https://doi.org/10.1016/j.eururo.2005.12.042spa
dc.relation.references22. Foo K. T. (2017). Pathophysiology of clinical benign prostatic hyperplasia. Asian journal of urology, 4(3), 152–157. https://doi.org/10.1016/j.ajur.2017.06.003spa
dc.relation.references23. Chia, S. J., Heng, C. T., Chan, S. P., & Foo, K. T. (2003). Correlation of intravesical prostatic protrusion with bladder outlet obstruction. BJU international, 91(4), 371–374. https://doi.org/10.1046/j.1464410x.2003.04088.xspa
dc.relation.references24. Lee, L. S., Sim, H. G., Lim, K. B., Wang, D., & Foo, K. T. (2010). Intravesical prostatic protrusion predicts clinical progression of benign prostatic enlargement in patients receiving medical treatment. International journal of urology : official journal of the Japanese Urological Association, 17(1), 69–74. https://doi.org/10.1111/j.14422042.2009.02409.xspa
dc.relation.references25. Jiang, H., & Zhou, Y. (2016). Safety and Efficacy of Thulium Laser Prostatectomy Versus Transurethral Resection of Prostate for Treatment of Benign Prostate Hyperplasia: A Meta-Analysis. Lower urinary tract symptoms, 8(3), 165–170. https://doi.org/10.1111/luts.12092spa
dc.relation.references26. Elmansy, H. M., Kotb, A., & Elhilali, M. M. (2011). Holmium laser enucleation of the prostate: long-term durability of clinical outcomes and complication rates during 10 years of followup. The Journal of urology, 186(5), 1972–1976. https://doi.org/10.1016/j.juro.2011.06.065.spa
dc.relation.references27. Zhang, X., Shen, P., He, Q., Yin, X., Chen, Z., Gui, H., Shu, KTang, Q., Yang, Y., Pan, X., Wang, J., Chen, N., & Zeng, H. (2016). Different lasers in the treatment of benign prostatic hyperplasia: a network meta-analysis. Scientific reports, 6, 23503. https://doi.org/10.1038/srep23503spa
dc.relation.references28. Herrmann, T. R., Liatsikos, E. N., Nagele, U., Traxer, O., Merseburger, A. S., & EAU Guidelines Panel on Lasers, Technologies (2012). EAU guidelines on laser technologies. European urology, 61(4), 783–795. https://doi.org/10.1016/j.eururo.2012.01.010spa
dc.relation.references29. Smith, R. D., & Patel, A. (2011). Transurethral resection of the prostate revisited and updated. Current opinion in urology, 21(1), 36–41. https://doi.org/10.1097/MOU.0b013e3283411455spa
dc.relation.references30. Lourenco, T., Armstrong, N., N'Dow, J., Nabi, G., Deverill, M., Pickard, R., Vale, L., MacLennan, G., Fraser, C., McClinton, S., Wong, S., Coutts, A., Mowatt, G., & Grant, A. (2008). Systematic review and economic modelling of effectiveness and cost utility of surgical treatments for men with benign prostatic enlargement. Health technology assessment (Winchester, England), 12(35), iii–515. https://doi.org/10.3310/hta12350spa
dc.relation.references31. Reich, O., Gratzke, C., Bachmann, A., Seitz, M., Schlenker, B., Hermanek, P., Lack, N., Stief, C. G., & Urology Section of the Bavarian Working Group for Quality Assurance (2008). Morbidity, mortality and early outcome of transurethral resection of the prostate: a prospective multicenter evaluation of 10,654 patients. The Journal of urology, 180(1), 246–249. https://doi.org/10.1016/j.juro.2008.03.058spa
dc.relation.references32. Cornu, J. N., Ahyai, S., Bachmann, A., de la Rosette, J., Gilling, P., Gratzke, C., McVary, K., Novara, G., Woo, H., & Madersbacher, S. (2015). A Systematic Review and Meta-analysis of Functional Outcomes and Complications Following Transurethral Procedures for Lower Urinary Tract Symptoms Resulting from Benign Prostatic Obstruction: An Update. European urology, 67(6), 1066–1096. https://doi.org/10.1016/j.eururo.2014.06.017spa
dc.relation.references33. Nestler, S., Bach, T., Herrmann, T., Jutzi, S., Roos, F. C., Hampel, C., Thüroff, J. W., Thomas, C., & Neisius, A. (2019). Surgictreatment of large volume prostates: a matched pair analysis comparing the open, endoscopic (ThuVEP) and robotic approach. World journal of urology, 37(9), 1927–1931. https://doi.org/10.1007/s00345-018-2585-zspa
dc.relation.references34. Parsons, J. K., Rangarajan, S. S., Palazzi, K., & Chang, D. (2015). A National, Comparative Analysis of Perioperative Outcomes of Open and Minimally Invasive Simple Prostatectomy. Journal of endourology, 29(8), 919–924. https://doi.org/10.1089/end.2014.0879spa
dc.relation.references35. Ou, R., You, M., Tang, P., Chen, H., Deng, X., & Xie, K. (2010). A randomized trial of transvesical prostatectomy versus transurethral resection of the prostate for prostate greater than 80 mL. Urology, 76(4), 958–961. https://doi.org/10.1016/j.urology.2010.01.079spa
dc.relation.references36. Ahyai, S. A., Lehrich, K., & Kuntz, R. M. (2007). Holmium laser enucleation versus transurethral resection of the prostate: 3-year followup results of a randomized clinical trial. European urology, 52(5), 1456– 1463. https://doi.org/10.1016/j.eururo.2007.04.053spa
dc.relation.references37. Gratzke, C., Bachmann, A., Descazeaud, A., Drake, M. J., Madersbacher, S., Mamoulakis, C., Oelke, M., Tikkinen, K., & Gravas, S. (2015). EAU Guidelines on the Assessment of Non-neurogenic Male Lower Urinary Tract Symptoms including Benign Prostatic Obstruction. European urology, 67(6), 1099–1109. https://doi.org/10.1016/j.eururo.2014.12.038spa
dc.relation.references38. Xia, S. J., Zhuo, J., Sun, X. W., Han, B. M., Shao, Y., & Zhang, Y. N. (2008). Thulium laser versus standard transurethral resection of the prostate: a randomized prospective trial. European urology, 53(2), 382– 389. https://doi.org/10.1016/j.eururo.2007.05.019spa
dc.relation.references39. Enikeev, D., Okhunov, Z., Rapoport, L., Taratkin, M., Enikeev, M., Snurnitsyna, O., Capretz, T., Inoyatov, J., & Glybochko, P. (2019). Novel Thulium Fiber Laser for Enucleation of Prostate: A Retrospective Comparison with Open Simple Prostatectomy. Journal of endourology, 33(1), 16–21. https://doi.org/10.1089/end.2018.0791spa
dc.relation.references40. Fried, N. M., & Murray, K. E. (2005). High-power thulium fiber laser ablation of urinary tissues at 1.94 microm. Journal of endourology19(1), 25–31. https://doi.org/10.1089/end.2005.19.25spa
dc.relation.references41. Li, M., Qiu, J., Hou, Q., Wang, D., Huang, W., Hu, C., Li, K., & Gao, X. (2015). Endoscopic enucleation versus open prostatectomy for treating large benign prostatic hyperplasia: a meta-analysis of randomized controlled trials. PloS one, 10(3), e0121265. https://doi.org/10.1371/journal.pone.0121265spa
dc.relation.references42. Liu, C., Zheng, S., Li, H., & Xu, K. (2010). Transurethral enucleation and resection of prostate in patients with benign prostatic hyperplasia by plasma kinetics. The Journal of urology, 184(6), 2440– 2445. https://doi.org/10.1016/j.juro.2010.08.037spa
dc.relation.references43. Noble, S. M., Ahern, A. M., Worthington, J., Hashim, H., Taylor, H., Young, G. J., Brookes, S., Abrams, P., Johnson, L., Khan, R., Page, T., Swami, K. S., & Lane, J. A. (2020). The cost-effectiveness of transurethral resection of the prostate vs thulium laser transurethral vaporesection of the prostate in the UNBLOCS randomised controlled trial for benign prostatic obstruction. BJU international, 126(5), 595–603. https://doi.org/10.1111/bju.15138spa
dc.relation.references44. Jiang, H., & Zhou, Y. (2016). Safety and Efficacy of Thulium Laser Prostatectomy Versus Transurethral Resection of Prostate for Treatment of Benign Prostate Hyperplasia: A Meta-Analysis. Lower urinary tract symptoms, 8(3), 165–170. https://doi.org/10.1111/luts.12092spa
dc.relation.references45. Zhu, Y., Zhuo, J., Xu, D., Xia, S., & Herrmann, T. R. (2015). Thulium laser versus standard transurethral resection of the prostate for benign prostatic obstruction: a systematic review and meta-analysis. World journal of urology, 33(4), 509–515. https://doi.org/10.1007/s00345-0141410-6spa
dc.rights.accessrightsinfo:eu-repo/semantics/openAccessspa
dc.rights.creativecommonsAtribución-NoComercial-SinDerivadas 2.5 Colombia*
dc.rights.localAbierto (Texto Completo)spa
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/2.5/co/*
dc.subject.keywordsMedical sciencesspa
dc.subject.keywordsHealth sciencesspa
dc.subject.keywordsUrologyspa
dc.subject.keywordsMedicinespa
dc.subject.keywordsThuliumspa
dc.subject.keywordsThuVepspa
dc.subject.keywordshuVapspa
dc.subject.keywordsOpen prostatectomyspa
dc.subject.keywordsProstate diseasesspa
dc.subject.keywordsHyperplasiaspa
dc.subject.keywordsCell pathologyspa
dc.subject.keywordsUrethroscopyspa
dc.subject.lembUrologíaspa
dc.subject.lembMedicinaspa
dc.subject.lembCiencias médicasspa
dc.subject.lembEnfermedades de la próstataspa
dc.subject.lembHiperplasiaspa
dc.subject.lembPatología celularspa
dc.subject.lembUretroscopiaspa
dc.subject.proposalCiencias de la saludspa
dc.subject.proposalHPBspa
dc.subject.proposalProstatectomía abiertaspa
dc.subject.proposalLáserspa
dc.titleVaporesección/ vapoenucleación de próstata con láser thulium frente a prostatectomía abierta en próstatas de alto volumenspa
dc.title.translatedVaporesection/ vapoenucleation of the prostate with thulium laser versus open prostatectomy in high-volume prostatesspa
dc.type.coarhttp://purl.org/coar/resource_type/c_bdcc
dc.type.coarversionhttp://purl.org/coar/version/c_ab4af688f83e57aaspa
dc.type.driverinfo:eu-repo/semantics/masterThesis
dc.type.hasversioninfo:eu-repo/semantics/acceptedVersion
dc.type.localTesisspa
dc.type.redcolhttp://purl.org/redcol/resource_type/TM

Archivos

Bloque original

Mostrando 1 - 2 de 2
Miniatura
Nombre:
2022_Tesis_Juan_Manuel_Sandoval.pdf
Tamaño:
862.91 KB
Formato:
Adobe Portable Document Format
Descripción:
Tesis
Descargar
Miniatura
Nombre:
2022_Licencia_Juan_Manuel_Sandoval.pdf
Tamaño:
195.3 KB
Formato:
Adobe Portable Document Format
Descripción:
Licencia
Descargar

Bloque de licencias

Mostrando 1 - 1 de 1
Miniatura
Nombre:
license.txt
Tamaño:
829 B
Formato:
Item-specific license agreed upon to submission
Descripción:
Descargar

Colecciones

Especialización en Urología